InsiderSignal.AI

InsiderSignal.ai

TWST - Twist Bioscience Corp

Insider Sale by Laponis Adam (CFO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Laponis Adam, serving as CFO at Twist Bioscience Corp (TWST), sold 2,597 shares at $49.89 per share, for a total transaction value of $129,562.00. Following this transaction, Laponis Adam now holds 125,694 shares of TWST.

This sale represents a 2.00% decrease in Laponis Adam's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, April 9, 2026 and publicly disclosed via SEC Form 4 filing on Monday, April 13, 2026, 4 days after the trade was made.

Twist Bioscience Corp operates in the HEALTHCARE sector, specifically within the DIAGNOSTICS & RESEARCH industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Laponis Adam

CFO

Adam Laponis is the Chief Financial Officer (CFO) of Twist Bioscience Corporation (NASDAQ: TWST), appointed effective January 5, 2024.[[2]](https://www.biospace.com/twist-bioscience-appoints-adam-laponis-as-chief-financial-officer)[[3]](https://paragonintel.com/new-cfo-hires-in-january-2024/) He previously served as CFO at Eargo, Inc., where he oversaw finance, accounting, investor relations, business operations, internal audit, and information technology, driving over 300% revenue growth in two years.[[1]](https://theorg.com/org/eargo/org-chart/adam-laponis)[[2]](https://www.biospace.com/twist-bioscience-appoints-adam-laponis-as-chief-financial-officer) Prior roles include Vice President of Worldwide Financial Planning & Analysis and Business Operations at Tesla, Inc., Vice President Finance and CFO of Cardiovascular Care at Cardinal Health, and various leadership positions at Johnson & Johnson, including leading the Cordis divestiture.[[1]](https://theorg.com/org/eargo/org-chart/adam-laponis)[[2]](https://www.biospace.com/twist-bioscience-appoints-adam-laponis-as-chief-financial-officer) Laponis began his career as a chemical engineer developing chiral separation techniques and later held roles such as Sr. Automation Engineer at BenefitPoint, Inc., and Summer Associate at Rosecreek Capital.[[1]](https://theorg.com/org/eargo/org-chart/adam-laponis) He holds an MBA from the University of Southern California Marshall School of Business and a B.S. in chemical engineering from the University of California, Berkeley.[[1]](https://theorg.com/org/eargo/org-chart/adam-laponis)[[2]](https://www.biospace.com/twist-bioscience-appoints-adam-laponis-as-chief-financial-officer)[[4]](https://twistbioscience.com/company/team) Recently, as a corporate insider, he sold 7,000 shares of TWST on February 12, 2026, at $50 per share.[[6]](https://www.marketbeat.com/instant-alerts/twist-bioscience-nasdaqtwst-cfo-adam-laponis-sells-7000-shares-2026-02-13/)

View full insider profile →

Trade Price

$49.89

Quantity

2,597

Total Value

$129,562.00

Shares Owned

125,694

Trade Date

Thursday, April 9, 2026

5 days ago

SEC Filing Date

Monday, April 13, 2026

Filed 4 days after trade

HEALTHCAREDIAGNOSTICS & RESEARCH

About Twist Bioscience Corp

Company Overview

No company information available
View news mentioning TWST

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/5612276

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime